AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20107897 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group (control)
Number of subjects: 80
Study 18553407 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Incident Stress Debriefing (CISD)
Number of subjects: 952
Study 18553407 — intervention group
Group type: COMPARATOR
Intervention: Stress Management Class (SMC)
Number of subjects: 952
Study 18553407 — intervention group
Group type: COMPARATOR
Intervention: Survey-Only (SO)
Number of subjects: 952
Study 15288885 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour milk drink (S-group, n = 23)
Number of subjects: 46
Study 15288885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acidified milk) drink (P-group, n = 23)
Number of subjects: 46
Study 11710724 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1-2 mg/day, adjusted to body weight)
Number of subjects: 116
Study 11710724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 9233134 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal commands at a level of language complexity above comprehension ability
Number of subjects: 15
Study 9233134 — intervention group
Group type: COMPARATOR
Intervention: Language matching comprehension ability
Number of subjects: 15
Study 7956999 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose, low fat snacks
Number of subjects: 18
Study 7956999 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat, low sucrose snacks
Number of subjects: 18
Study 7956999 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy lunch
Number of subjects: 18
Study 2958783 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaprazine (1.5 mg/kg/day)
Number of subjects: 20
Study 2958783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29674417 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative collateral score
Number of subjects: 442
Study 26453952 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy (30‐35 kcal/kg/d, 1.0‐1.5 g vegetable protein/kg/d)
Number of subjects: 120
Study 26453952 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy
Number of subjects: 120
Study 26453952 — intervention group
Group type: COMPARATOR
Intervention: Control (no nutritional therapy)
Number of subjects: 120
Study 25142287 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 21
Study 25142287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 22006050 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg daily
Number of subjects: 37
Study 22006050 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 37
Study 20713274 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked intramedullary fixation
Number of subjects: 32
Study 20713274 — intervention group
Group type: COMPARATOR
Intervention: Plating
Number of subjects: 32
Study 17414804 — intervention group
Group type: EXPERIMENTAL
Intervention: 15/15 interval running (15 s of running at 90‐95% HRmax followed by 15 s of active resting at 70% HRmax)
Number of subjects: 40
Study 17414804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 x 4 min of interval running (4 min of running at 90‐95% HRmax followed by 3 min of active resting at 70% HRmax)
Number of subjects: 40
Study 17414804 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic interval training
Number of subjects: 40
Study 17414804 — intervention group
Group type: COMPARATOR
Intervention: Long slow distance (70% HRmax)
Number of subjects: 40
Study 17414804 — intervention group
Group type: COMPARATOR
Intervention: Lactate threshold (85% HRmax)
Number of subjects: 40
Study 15978776 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin bone
Number of subjects: 15
Study 15978776 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin bone with GBR membrane
Number of subjects: 15
Study 15978776 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐Oss with GBR membrane
Number of subjects: 15
Study 15978776 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 15
Study 12190798 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic tube compensation (ATC)
Number of subjects: 90
Study 12190798 — intervention group
Group type: COMPARATOR
Intervention: Conventional pressure support ventilation (PSV, 5 cmH2O)
Number of subjects: 90
Study 12190798 — intervention group
Group type: COMPARATOR
Intervention: T-tube
Number of subjects: 90
Study 10530967 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa-carbidopa (2.08 mg/kg of body weight)
Number of subjects: 14
Study 10530967 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa-carbidopa (0.62 mg/kg of body weight)
Number of subjects: 14
Study 10530967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 7721374 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose)
Number of subjects: 150
Study 7721374 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (22.5 mg/kg/day for 5 days in 3 divided doses)
Number of subjects: 150
Study 2466547 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic strategies from 1972 to 1983
Number of subjects: 1006
Study 2466547 — intervention group
Group type: EXPERIMENTAL
Intervention: Children surviving in first remission beyond 5 years
Number of subjects: 1006
Study 2466547 — intervention group
Group type: EXPERIMENTAL
Intervention: Marrow relapse
Number of subjects: 1006
Study 2466547 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte count
Number of subjects: 1006
Study 2466547 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants
Number of subjects: 1006
Study 30897128 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring for children (specifically after the first and second child)
Number of subjects: 95
Study 30897128 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring for children
Number of subjects: 95
Study 28080306 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult IKDC Subjective Knee Evaluation
Number of subjects: 100
Study 28080306 — intervention group
Group type: COMPARATOR
Intervention: Pediatric IKDC Subjective Knee Evaluation
Number of subjects: 100
Study 26799572 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load ischemic knee-extension exercise (ISHEMIC group)
Number of subjects: 20
Study 26799572 — intervention group
Group type: COMPARATOR
Intervention: Standard knee-extension exercise (SHAM group)
Number of subjects: 20
Study 24559210 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for physical activity with 'views‐on‐ageing'‐component (IGVoA)
Number of subjects: 234
Study 24559210 — intervention group
Group type: COMPARATOR
Intervention: Intervention for physical activity without 'views‐on‐ageing'‐component (IG)
Number of subjects: 234
Study 24559210 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention for volunteering (CG)
Number of subjects: 234
Study 21785963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy with cultural tailoring intervention
Number of subjects: 30
Study 21785963 — intervention group
Group type: COMPARATOR
Intervention: Brief medication management (Control)
Number of subjects: 30
Study 19350340 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg/day
Number of subjects: 427
Study 19350340 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 10 mg/day
Number of subjects: 427
Study 19350340 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 427
Study 19350340 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 427
Study 17254760 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) extrafine 200 microg day(-1)
Number of subjects: 280
Study 17254760 — intervention group
Group type: COMPARATOR
Intervention: CFC-fluticasone propionate (CFC-FP) 200 microg day(-1)
Number of subjects: 280
Study 17254760 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) extrafine
Number of subjects: 280
Study 17254760 — intervention group
Group type: COMPARATOR
Intervention: CFC-fluticasone propionate (CFC-FP)
Number of subjects: 280
Study 17254760 — intervention group
Group type: EXPERIMENTAL
Intervention: Both BDP extrafine and CFC-FP
Number of subjects: 280
Study 15284603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density surface EMG (SEMG) at 20% of maximal voluntary contraction (MVC)
Number of subjects: 7
Study 15284603 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle EMG
Number of subjects: 7
Study 11258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator-applied 2-octyl cyanoacrylate (2-OCA) tissue adhesive
Number of subjects: 200
Study 11258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-applied 2-octyl cyanoacrylate (2-OCA) tissue adhesive
Number of subjects: 200
Study 11258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicate device approved by the U.S. FDA
Number of subjects: 200
Study 10210044 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Positive-Pressure Ventilation (IPPV) with 50% N2O
Number of subjects: 120
Study 10210044 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous Ventilation (SV) with 50% N2O
Number of subjects: 120
Study 10210044 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Positive-Pressure Ventilation (IPPV) with 66% N2O
Number of subjects: 120
Study 10210044 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous Ventilation (SV) with 66% N2O
Number of subjects: 120
Study 10210044 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of postoperative discomfort
Number of subjects: 120
Study 7880101 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 2146756 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisone and local anesthetic injected intra-articularly
Number of subjects: 109
Study 2146756 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisone and local anesthetic injected pericapsularly
Number of subjects: 109
Study 2146756 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic sodium hydrochloride injected intra-articularly into two facet joints
Number of subjects: 109
Study 2146756 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 109
Study 946886 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically treated patients
Number of subjects: 0
Study 946886 — intervention group
Group type: COMPARATOR
Intervention: Surgically treated patients
Number of subjects: 0
Study 31303390 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% calorie restriction diet
Number of subjects: 218
Study 31303390 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum control diet
Number of subjects: 218
Study 28381516 — intervention group
Group type: COMPARATOR
Intervention: Placebo group from NIA trials (ADCS and ADNI)
Number of subjects: 0
Study 28381516 — intervention group
Group type: COMPARATOR
Intervention: Placebo group from industry-sponsored trials (rivastigmine, galantamine, rofecoxib, donepezil)
Number of subjects: 0
Study 28381516 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE4 carrier status
Number of subjects: 0
Study 25790018 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven-day week therapy (usual care physiotherapy provided seven-days a week)
Number of subjects: 283
Study 25790018 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit class therapy (physiotherapy in group circuit classes in two 90-min sessions, five-days a week)
Number of subjects: 283
Study 25790018 — intervention group
Group type: COMPARATOR
Intervention: Usual care (individual physiotherapy provided five-days a week)
Number of subjects: 283
Study 23552182 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 400 mg
Number of subjects: 29
Study 23552182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 21347997 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional herbal medicines
Number of subjects: 0
Study 21347997 — intervention group
Group type: EXPERIMENTAL
Intervention: Active plants or bioactive phytoconstituents
Number of subjects: 0
Study 20008182 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel therapies that increase fetal hemoglobin production, improve red blood cell hydration, increase nitric oxide availability, and possess anti-inflammatory effects
Number of subjects: 0
Study 17400858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic surgical aspiration
Number of subjects: 110
Study 17400858 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 110
Study 17400858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 110
Study 15243932 — intervention group
Group type: EXPERIMENTAL
Intervention: V‐TT conjugate vaccine (n=22)
Number of subjects: 32
Study 15243932 — intervention group
Group type: COMPARATOR
Intervention: Licensed tetanus-diphtheria toxoid vaccine (Td) (n=10)
Number of subjects: 32
Study 11565421 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning every 4 hours on a pressure reducing viscoelastic mattress
Number of subjects: 838
Study 11565421 — intervention group
Group type: COMPARATOR
Intervention: Turning every 6 hours on a viscoelastic mattress
Number of subjects: 838
Study 11565421 — intervention group
Group type: COMPARATOR
Intervention: Turning every 2 hours on a non-pressure reducing mattress
Number of subjects: 838
Study 11565421 — intervention group
Group type: COMPARATOR
Intervention: Turning every 4 hours on a non-pressure reducing mattress
Number of subjects: 838
Study 10898560 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia program
Number of subjects: 108
Study 10898560 — intervention group
Group type: COMPARATOR
Intervention: Written brochure
Number of subjects: 108
Study 1537478 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk containing 10(8)/g Lactobacillus acidophilus and 10(7)/g Bifidobacterium sp
Number of subjects: 6
Study 1537478 — intervention group
Group type: COMPARATOR
Intervention: Sterilized fermented milk
Number of subjects: 6
Study 6231947 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 370
Study 6231947 — intervention group
Group type: COMPARATOR
Intervention: Carbon dioxide
Number of subjects: 370
Study 6231947 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods of enhancing gas recovery
Number of subjects: 370
Study 31594375 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 100
Study 31594375 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal saline)
Number of subjects: 100
Study 29625435 — intervention group
Group type: EXPERIMENTAL
Intervention: CLR bilingual approach
Number of subjects: 42
Study 29625435 — intervention group
Group type: COMPARATOR
Intervention: English-only group
Number of subjects: 42
Study 27410961 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning intervention (n = 270)
Number of subjects: 1217
Study 27410961 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention (n = 311)
Number of subjects: 1217
Study 27410961 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy+planning intervention (n = 351)
Number of subjects: 1217
Study 27410961 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 285)
Number of subjects: 1217
Study 24347773 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/2 ml DEZ
Number of subjects: 75
Study 24347773 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% LID
Number of subjects: 75
Study 24347773 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (normal saline)
Number of subjects: 75
Study 21831266 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (gemcitabine 1000 mg/m(2), oxaliplatin 100 mg/m(2)) followed by surgery and adjuvant gemcitabine (1000 mg/m(2) for 6 months)
Number of subjects: 310
Study 21831266 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant gemcitabine (1000 mg/m(2) for 6 months) after surgery
Number of subjects: 310
Study 19601477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with outreach worker (connector) facilitating participation in recreational activities
Number of subjects: 360
Study 19601477 — intervention group
Group type: COMPARATOR
Intervention: Control group without outreach worker
Number of subjects: 360
Study 19601477 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with higher levels of contact with connectors
Number of subjects: 360
Study 19601477 — intervention group
Group type: COMPARATOR
Intervention: Children with lower levels of contact with connectors
Number of subjects: 360
Study 17694216 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished and coated with bonding agent
Number of subjects: 0
Study 17694216 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished and coated with light‐cured liquid polish
Number of subjects: 0
Study 17694216 — intervention group
Group type: COMPARATOR
Intervention: Polished surface
Number of subjects: 0
Study 14734067 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine
Number of subjects: 64
Study 14734067 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed and alkalinized lidocaine
Number of subjects: 64
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Board certified psychiatrists
Number of subjects: 278
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatrists with less practice experience
Number of subjects: 278
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatrists with a greater percentage of patients on managed care
Number of subjects: 278
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatrists with a greater percentage of patients on psychotropic medications
Number of subjects: 278
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Male psychiatrists
Number of subjects: 278
Study 11815683 — intervention group
Group type: EXPERIMENTAL
Intervention: Less satisfied psychiatrists
Number of subjects: 278
Study 9612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiotherapy
Number of subjects: 0
Study 9612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended neoadjuvant treatment concepts including chemotherapy
Number of subjects: 0
Study 9612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy and hyperthermia combined with radiochemotherapy
Number of subjects: 0
Study 9612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal surgical treatment
Number of subjects: 0
Study 7646574 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily
Number of subjects: 36
Study 7646574 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily
Number of subjects: 36
Study 7646574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 2753302 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg/day) for 6 months
Number of subjects: 67
Study 2753302 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 67
Study 2753302 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg/day)
Number of subjects: 67
Study 2753302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 333607 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin (M)
Number of subjects: 261
Study 333607 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin (C)
Number of subjects: 261
Study 31865457 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex with hormonal contraception; Counseling provided: 0.7% (1 out of 134 women) had documented counseling on drug-drug interaction.
Number of subjects: 134
Study 31865457 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex exposure; Outcome: 1 unintended pregnancy reported within the same cycle as sugammadex exposure.
Number of subjects: 134
Study 31101037 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain prevention intervention with tailored behavior change goals, daily weighing on a network-connected electronic scale, and responsive weight and goal coaching delivered remotely by health center registered dietitians.
Number of subjects: 0
Study 31101037 — intervention group
Group type: COMPARATOR
Intervention: Usual care program with automated healthy living text messages and print materials and routine primary care.
Number of subjects: 0
Study 28296911 — intervention group
Group type: EXPERIMENTAL
Intervention: cART for 24 weeks
Number of subjects: 47
Study 28296911 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 47
Study 25645329 — intervention group
Group type: EXPERIMENTAL
Intervention: Two sessions of PN counseling (experimental group)
Number of subjects: 84
Study 25645329 — intervention group
Group type: COMPARATOR
Intervention: One session of PN counseling (control group)
Number of subjects: 84
Study 23052115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet inflated just before incision and deflated after hardening of cement (Group 1)
Number of subjects: 36
Study 23052115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet inflated just before cement application and deflated after hardening (Group 2)
Number of subjects: 36
Study 23052115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet inflated before incision and deflated after last suture (Group 3)
Number of subjects: 36
Study 21219918 — intervention group
Group type: EXPERIMENTAL
Intervention: grapheme-color correspondences
Number of subjects: 52
Study 19320235 — intervention group
Group type: EXPERIMENTAL
Intervention: CLA 2 g/day for 4 weeks before and 4 days following intranasal HRV inoculation
Number of subjects: 130
Study 19320235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 17050768 — intervention group
Group type: EXPERIMENTAL
Intervention: Semistructured Interview for Consideration of Ethnic Culture in Therapy Scale (SSICECTS)
Number of subjects: 279
Study 17050768 — intervention group
Group type: COMPARATOR
Intervention: Parallel semistructured interview regarding exercise
Number of subjects: 279
Study 12757530 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual presentation format
Number of subjects: 200
Study 12757530 — intervention group
Group type: COMPARATOR
Intervention: Written presentation format
Number of subjects: 200
Study 10694141 — intervention group
Group type: EXPERIMENTAL
Intervention: CREATINE (5 g of Cr, four times per day for 6 d)
Number of subjects: 17